Search

Author/Creator Jones, Suzanne F.

1. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. (March 2016)

Authors:
Pant, Shubham; Jones, Suzanne F.; Kurkjian, Carla D.; Infante, Jeffrey R.; Moore, Kathleen N.; Burris, Howard A.; McMeekin, Donald S.; Benhadji, Karim A.; Patel, Bharvin K.R.; Frenzel, Martin J.; Kursar, Jonathan D.; Zamek-Gliszczynski, Maciej J.; Yuen, Eunice S.M.; Chan, Edward M.; Bendell, Joha...
Journal:
European journal of cancer
Issue:
Volume 56(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. (March 2016)

Authors:
Pant, Shubham; Jones, Suzanne F.; Kurkjian, Carla D.; Infante, Jeffrey R.; Moore, Kathleen N.; Burris, Howard A.; McMeekin, Donald S.; Benhadji, Karim A.; Patel, Bharvin K.R.; Frenzel, Martin J.; Kursar, Jonathan D.; Zamek-Gliszczynski, Maciej J.; Yuen, Eunice S.M.; Chan, Edward M.; Bendell, Joha...
Journal:
European journal of cancer
Issue:
Volume 56(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors. (26th November 2015)

Authors:
Bendell, Johanna C.; Jones, Suzanne F.; Hart, Lowell; Pant, Shubham; Moyhuddin, Adil; Lane, Cassie M.; Earwood, Chris; Murphy, Patrick; Patton, Jeffrey; Penley, William C.; Thompson, Dana; Infante, Jeffrey R.
Journal:
Cancer investigation
Issue:
Volume 33:Number 10(2015)
Page Start:
477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial. (16th August 2019)

Authors:
Spigel, David R.; Shipley, Dianna L.; Waterhouse, David M.; Jones, Suzanne F.; Ward, Patrick J.; Shih, Kent C.; Hemphill, Brian; McCleod, Michael; Whorf, Robert C.; Page, Ray D.; Stilwill, Joseph; Mekhail, Tarek; Jacobs, Cindy; Burris, Howard A.; Hainsworth, John D.
Journal:
Oncologist
Issue:
Volume 24:Number 12(2019)
Page Start:
e1409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics. (August 2021)

Authors:
Sturgill, Emma G.; Misch, Amanda; Lachs, Rebecca; Jones, Carissa C.; Schlauch, Dan; Jones, Suzanne F.; Shastry, Mythili; Yardley, Denise A.; Burris, Howard A.; Spigel, David R.; Hamilton, Erika P.; McKenzie, Andrew J.
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase 1, open‐label, dose escalation, safety, and pharmacokinetics study of ME‐344 as a single agent in patients with refractory solid tumors. Issue 7 (19th November 2014)

Authors:
Bendell, Johanna C.; Patel, Manish R.; Infante, Jeffrey R.; Kurkjian, Carla D.; Jones, Suzanne F.; Pant, Shubham; Burris, Howard A.; Moreno, Ofir; Esquibel, Vanessa; Levin, Wendy; Moore, Kathleen N.
Journal:
Cancer
Issue:
Volume 121:Issue 7(2015)
Page Start:
1056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗